Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Giant Biogene Holding Co. Ltd. (HK:2367)
HKEX:2367
Giant Biogene Holding Co. Ltd. (2367) Stock Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
2367 Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2367 Stock 12 Month Forecast
Average Price Target
HK$55.00
▲(33.33% Upside)
| Highest Price TargetHK$55.00 | Average Price TargetHK$55.00 | Lowest Price TargetHK$55.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
CMB International Securities
HK$48.87
Buy
HK$48.87
(18.47% Upside)
Initiated
11/27/23
We expect Giant Biogene to have two injectable recombinant collagen products to be approved in 2024E, and another two injectable products to be approved in 2025E. Given Giant Biogene has already built an extensive distribution network and has established strong brand recognition among medical institutions, we think the Company will quickly ramp up its injectable recombinant collagen product sales upon commercialization. Initiate at BUY with TP of HK$48.87. We expect Comfy to be the major revenue driver in 2023E-25E. We derive our target price of HK$48.87 based on DCF valuation (WACC: 11.1%, terminal growth rate: 3.0%), implying 27x 25.3% earnings CAGR in 2022-25E.
Unknown Analyst
Not Ranked
UBS
HK$43.3
Buy
HK$43.30
(4.97% Upside)
Initiated
08/29/23
UBS Starts Giant Biogene Holding Co (2367:HK) at BuyUBS analyst Ingrid Zhang initiates coverage on Giant Biogene Holding Co (2367:HK) with a Buy rating and a price target of HK$43.30.
―
Goldman Sachs
―
Buy
―
Reiterated
05/06/24
Giant Biogene Holding Co (2367:HK) PT Raised to HK$55 at Goldman SachsGoldman Sachs raised its price target on Giant Biogene Holding Co (2367:HK) to HK$55.00 (from HK$48.00) while maintaining a Buy rating.
Best Analysts Covering Giant Biogene Holding Co. Ltd.
Which Analyst Should I Follow If I Want to Buy HK:2367 and Sell After:
1 Month
xxx
Success Rate
0/1 ratings generated profit
Average Return
-0.60%
initiated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -0.60% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
Average Return
+1.10%
initiated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +1.10% per trade.
1 Year
Success Rate
1/1 ratings generated profit
Average Return
+18.50%
initiated a buy rating 8 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +18.50% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
Average Return
+18.50%
initiated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +18.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2367 Analyst Recommendation Trends
Rating
Aug 23
Nov 23
May 24
Jun 24
Strong Buy
0
0
0
0
Buy
1
3
4
4
Hold
0
0
0
0
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
3
4
4
Each month's total comprises the sum of three months' worth of ratings.
2367 Financial Forecast
2367 Stock Forecast FAQ
What is HK:2367’s average 12-month price target, according to analysts?
Based on analyst ratings, Giant Biogene Holding Co. Ltd.’s 12-month average price target is HK$55.00.
What is HK:2367’s upside potential, based on the analysts’ average price target?
Giant Biogene Holding Co. Ltd. has 33.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Giant Biogene Holding Co. Ltd. a Buy, Sell or Hold?
Giant Biogene Holding Co. Ltd. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Giant Biogene Holding Co. Ltd.’s share price target?
The average share price target for Giant Biogene Holding Co. Ltd. is HK$55.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$55.00 ,and the lowest forecast is HK$55.00. The average share price target represents 33.33% Increase from the current price of HK$41.25.
The highest analyst share price target is HK$55.00 ,and the lowest forecast is HK$55.00. The average share price target represents 33.33% Increase from the current price of HK$41.25.
What do analysts say about Giant Biogene Holding Co. Ltd.?
Giant Biogene Holding Co. Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Giant Biogene Holding Co. Ltd.?
To buy shares of HK:2367, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.